Effects of lipoprotein apheresis on PCSK9 levels.
Julius U, Milton M, Stoellner D, Rader D, Gordon B, Polk D, Waldmann E, Parhofer KG, Moriarty PM.
Julius U, et al. Among authors: parhofer kg.
Atheroscler Suppl. 2015 May;18:180-6. doi: 10.1016/j.atherosclerosissup.2015.02.028.
Atheroscler Suppl. 2015.
PMID: 25936324